Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mehtali

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|July 1, 1997
Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient miceK Sanhadji, P Leissner, R Firouzi, et al.
Journal of Virology|September 11, 1999
Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3M Lusky, L Grave, A Dieterlé, et al.
Human Gene Therapy|February 15, 2001
Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapyS Lerondel, A Le Pape, C Sené, et al.
The Journal of General Virology|June 22, 1999
Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CARG Santis, V Legrand, S S Hong, et al.
Cancer Gene Therapy|June 8, 1999
Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumorsC F Rochlitz, P Jantscheff, G Bongartz, et al.
AIDS Research and Human Retroviruses|July 20, 1997
Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1C S Dunn, B Hurtrel, C Beyer, et al.
Gene Therapy|November 18, 2000
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cellsD Nègre, P E Mangeot, G Duisit, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infectionsJ Estaquier, T Idziorek, F de Bels, et al.
British Journal of Cancer|November 15, 2000
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findingsE Tartour, M Mehtali, X Sastre-Garau, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|July 1, 1997
Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient miceK Sanhadji, P Leissner, R Firouzi, et al.
Journal of Virology|September 11, 1999
Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3M Lusky, L Grave, A Dieterlé, et al.
Human Gene Therapy|February 15, 2001
Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapyS Lerondel, A Le Pape, C Sené, et al.
The Journal of General Virology|June 22, 1999
Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CARG Santis, V Legrand, S S Hong, et al.
Cancer Gene Therapy|June 8, 1999
Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumorsC F Rochlitz, P Jantscheff, G Bongartz, et al.
AIDS Research and Human Retroviruses|July 20, 1997
Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1C S Dunn, B Hurtrel, C Beyer, et al.
Gene Therapy|November 18, 2000
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cellsD Nègre, P E Mangeot, G Duisit, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infectionsJ Estaquier, T Idziorek, F de Bels, et al.
British Journal of Cancer|November 15, 2000
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findingsE Tartour, M Mehtali, X Sastre-Garau, et al.
Pageof 7